250 related articles for article (PubMed ID: 22270809)
1. Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.
Naidoo V; Karanian DA; Vadivel SK; Locklear JR; Wood JT; Nasr M; Quizon PM; Graves EE; Shukla V; Makriyannis A; Bahr BA
Neurotherapeutics; 2012 Oct; 9(4):801-13. PubMed ID: 22270809
[TBL] [Abstract][Full Text] [Related]
2. A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity.
Naidoo V; Nikas SP; Karanian DA; Hwang J; Zhao J; Wood JT; Alapafuja SO; Vadivel SK; Butler D; Makriyannis A; Bahr BA
J Mol Neurosci; 2011 Mar; 43(3):493-502. PubMed ID: 21069475
[TBL] [Abstract][Full Text] [Related]
3. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
4. The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?
Bajaj S; Jain S; Vyas P; Bawa S; Vohora D
Brain Res Bull; 2021 Sep; 174():305-322. PubMed ID: 34217798
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage.
Karanian DA; Karim SL; Wood JT; Williams JS; Lin S; Makriyannis A; Bahr BA
J Pharmacol Exp Ther; 2007 Sep; 322(3):1059-66. PubMed ID: 17545313
[TBL] [Abstract][Full Text] [Related]
6. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.
Karanian DA; Brown QB; Makriyannis A; Kosten TA; Bahr BA
J Neurosci; 2005 Aug; 25(34):7813-20. PubMed ID: 16120783
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.
Fucich EA; Stielper ZF; Cancienne HL; Edwards S; Gilpin NW; Molina PE; Middleton JW
J Neurophysiol; 2020 Feb; 123(2):707-717. PubMed ID: 31913777
[TBL] [Abstract][Full Text] [Related]
8. A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.
Parker LA; Limebeer CL; Rock EM; Sticht MA; Ward J; Turvey G; Benchama O; Rajarshi G; Wood JT; Alapafuja SO; Makriyannis A
Psychopharmacology (Berl); 2016 Jun; 233(12):2265-75. PubMed ID: 27048155
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
11. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase.
Clement AB; Hawkins EG; Lichtman AH; Cravatt BF
J Neurosci; 2003 May; 23(9):3916-23. PubMed ID: 12736361
[TBL] [Abstract][Full Text] [Related]
12. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
13. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s).
Suzuki H; Ito Y; Noro Y; Koketsu M; Kamijima M; Tomizawa M
Toxicol Lett; 2014 Feb; 225(1):153-7. PubMed ID: 24361246
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon.
Farizatto KLG; McEwan SA; Naidoo V; Nikas SP; Shukla VG; Almeida MF; Byrd A; Romine H; Karanian DA; Makriyannis A; Bahr BA
J Mol Neurosci; 2017 Sep; 63(1):115-122. PubMed ID: 28803438
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
16. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
[TBL] [Abstract][Full Text] [Related]
17. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
Hruba L; Seillier A; Zaki A; Cravatt BF; Lichtman AH; Giuffrida A; McMahon LR
J Pharmacol Exp Ther; 2015 May; 353(2):261-8. PubMed ID: 25711338
[TBL] [Abstract][Full Text] [Related]
19. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.
Della Pietra A; Giniatullin R; Savinainen JR
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530477
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
Jaiswal S; Ayyannan SR
ChemMedChem; 2021 Jul; 16(14):2172-2187. PubMed ID: 33834617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
